Rank #33

Incannex Healthcare Inc.

IXHL

$2.9799

-3.56% (24h)

Last updated: 1 second ago

Market Cap

$35.65M

Volume (24h)

128.87K

Last Close (7D)

$2.98

View on TradingView

Price Chart

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

Website

www.incannex.com

Country

🇦🇺 Australia

An Australian clinical-stage pharmaceutical company developing combination cannabinoid and psychedelic medicines for sleep apnea, general anxiety, PTSD, and traumatic brain injury.

🌏 Australia has embraced therapeutic cannabinoids and psychedelics earlier than most Western markets — first-mover advantage

Key Stats

52-Week Range

$2.49$49.80

Beta2.84

Trailing P/EN/A

Forward P/E-1.52

Trailing EPS-16.62

Avg Volume498.54K

Enterprise Value$-37.37M

Shares Outstanding11.96M

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Latest News

Benzinga · May 15, 2026
Incannex Healthcare Q3 EPS $(0.35) Beats $(0.79) Estimate
Yahoo · May 14, 2026
Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea
Finnhub · May 14, 2026
Incannex Healthcare commences Dreamzz clinical study of IHL-42X for obstructive sleep apnea
Yahoo · May 12, 2026
Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development